As a relatively accessible and cost-efficient synthetic fibrous membrane, the rhACE2 patch was designed to release bioactive rhACE2 continuously, for further inducing local AngII to transform into Ang1–7, reversing post-MI fibrosis and preventing ventricle remodeling. The gene discussed is AGT; the disease is myocardial infarction.